Lupus nephritis management guidelines compared

被引:82
作者
Wilhelmus, Suzanne [1 ]
Bajema, Ingeborg M. [1 ]
Bertsias, George K. [2 ,3 ]
Boumpas, Dimitrios T. [3 ,4 ]
Gordon, Caroline [5 ]
Lightstone, Liz [6 ]
Tesar, Vladimir [7 ]
Jayne, David R. [8 ]
机构
[1] Leiden Univ, Med Ctr, Dept Pathol, Leiden, Netherlands
[2] Univ Crete, Sch Med, Rheumatol Clin Immunol & Allergy, Iraklion, Greece
[3] FORTH, IMBB, Infect & Immun Div, Iraklion, Greece
[4] Acad Athens, Biomed Res Fdn, Athens, Greece
[5] Univ Birmingham, Coll Med & Dent Sci, Sch Immun & Infect, Rheumatol Res Grp,Med Sch, Birmingham, W Midlands, England
[6] Imperial Coll London, Dept Med, Sect Renal Med & Vasc Inflammat, London, England
[7] Charles Univ Prague, Sch Med 1, Dept Nephrol, Prague, Czech Republic
[8] Addenbrookes Hosp, Lupus & Vasculitis Unit, Cambridge, England
关键词
guideline; lupus nephritis; management; systemic lupus erythematosus; treatment; MYCOPHENOLATE-MOFETIL; MEMBRANOUS NEPHROPATHY; MAINTENANCE THERAPY; INDUCTION THERAPY; EUROPEAN LEAGUE; RENAL BIOPSY; ERYTHEMATOSUS; AZATHIOPRINE; RITUXIMAB; CYCLOPHOSPHAMIDE;
D O I
10.1093/ndt/gfv102
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
In the past years, many (randomized) trials have been performed comparing the treatment strategies for lupus nephritis. In 2012, these data were incorporated in six different guidelines for treating lupus nephritis. These guidelines are European, American and internationally based, with one separate guideline for children. They offer information on different aspects of the management of lupus nephritis including induction and maintenance treatment of the different histological classes, adjunctive treatment, monitoring of the patient, definitions of response and relapse, indications for (repeat) renal biopsy, and additional challenges such as the presence of vascular complications, the pregnant SLE patient, treatment in children and adolescents and considerations about end-stage renal disease and transplantation. In this review, we summarize the guidelines, determine the common ground between them, highlight the differences and discuss recent literature.
引用
收藏
页码:904 / 913
页数:10
相关论文
共 50 条
  • [21] Impact of the ALMS and MAINTAIN trials on the management of lupus nephritis
    Morris, Heather K.
    Canetta, Pietro A.
    Appel, Gerald B.
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 (06) : 1371 - 1376
  • [22] Predictors of treatment response in a lupus nephritis population: lessons from the Aspreva Lupus Management Study (ALMS) trial
    McDonald, Stephen
    Yiu, Sean
    Su, Li
    Gordon, Caroline
    Truman, Matt
    Lisk, Laura
    Solomons, Neil
    Bruce, Ian N.
    [J]. LUPUS SCIENCE & MEDICINE, 2022, 9 (01):
  • [23] Ten tips in lupus nephritis management
    Teoh, Selene T. Y.
    Yap, Desmond Y. H.
    Chan, Tak Mao
    [J]. CLINICAL KIDNEY JOURNAL, 2025, 18 (01)
  • [24] Management of Lupus Nephritis
    Tamirou, Farah
    Houssiau, Frederic A.
    [J]. JOURNAL OF CLINICAL MEDICINE, 2021, 10 (04) : 1 - 11
  • [25] Egyptian evidence-based consensus on clinical practice recommendations for the management of lupus nephritis
    El Miedany, Yasser
    Kamel, Nadia Salah
    Abu-Zaid, Mohammed Hassan
    El Hadidi, Khaled
    Mahmoud, Geilan Abdelmoneim
    Sarhan, Eman
    El Gaafary, Maha
    Abdel-Nasser, Ahmed
    Abualfadl, Esam M.
    Azim, Atef Abdel
    Fathi, Nihal Ahmed
    Mokbel, Abir
    Hassan, Waleed
    Tabra, Samar Abd Alhamed
    Eissa, Mervat
    Mortada, Mohamed
    Fouad, Nermeen Ahmed
    Elnemr, Rehab
    Mansour, Ahmed Ezzat
    Elaraby, Ismail
    Medhat, Basma M.
    Mohamed, Sally S.
    Abdelradi, Eman Ragab
    Ibrahim, Rehab Ali
    Saber, Sally
    [J]. EGYPTIAN RHEUMATOLOGY AND REHABILITATION, 2022, 49 (01)
  • [26] Rituximab treatment in lupus nephritis - where do we stand?
    Gunnarsson, I.
    Jonsdottir, T.
    [J]. LUPUS, 2013, 22 (04) : 381 - 389
  • [27] Clinical guideline for the treatment of lupus nephritis and single-centre results of mycofenolate mofetil among patients with lupus nephritis in the National Institute of Rheumatology and Physiotherapy, Budapest
    Szabo Melinda Zsuzsanna
    Kiss Emese
    [J]. ORVOSI HETILAP, 2016, 157 (35) : 1385 - 1393
  • [28] Lupus nephritis: from diagnosis to treatment
    Weinmann-Menke, Julia
    [J]. INNERE MEDIZIN, 2023, : 225 - 233
  • [29] Lupus nephritis: where are we now?
    Lightstone, Liz
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2010, 22 (03) : 252 - 256
  • [30] CONNECTIVE TISSUE DISEASES Management of lupus nephritis-new guidelines revealed
    Ginzler, Ellen
    [J]. NATURE REVIEWS RHEUMATOLOGY, 2012, 8 (10) : 565 - 566